Munafa Stock Market Course + Intraday & FNO calls 
Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)
Technical Analysis Report for NASDAQ stock BOLD Audentes Therapeutics. Dated: 04 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics
Audentes Therapeutics Opened at 1.14 and Closed at: 1.14, which is 0.88% of previous session's close. It moved within a range of 1.14 and 1.16
The session was a Neutral session with an average volume of 10900, which is -522.94% of previous session's volumes.
A Golden cross was found 7 days back on short term averages
Support for tomorrow is 1.13 and resistance for tomorrow is 1.15
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.13, 1.13 resistance for tomorrow's hourly charts is 1.15, 1.17
10 Day SMA for Audentes Therapeutics (BOLD) is 1.16 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Audentes Therapeutics (BOLD) is 1.15 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Audentes Therapeutics (BOLD) is 1.19 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.22 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Audentes Therapeutics is 1.2 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Audentes Therapeutics is at 1.15 and 200 DMA is at 1.2, while 50 DMA and 100 DMA are at 1.19 and 1.22 respectively
Audentes Therapeutics (BOLD) moving average of 20 SMA is at 1.15 and 20 EMA is at 1.16
| Date | Closing Price | 20 SMA | 20 EMA |
| 04 Wed Mar | 1.14 | 1.15 | 1.16 |
| 03 Tue Mar | 1.13 | 1.14 | 1.16 |
| 02 Mon Mar | 1.16 | 1.14 | 1.16 |
| 27 Fri Feb | 1.16 | 1.14 | 1.16 |
| 26 Thu Feb | 1.16 | 1.14 | 1.16 |
| 25 Wed Feb | 1.17 | 1.14 | 1.16 |
Audentes Therapeutics (BOLD) moving average of 50 SMA is at 1.19 and 50 EMA is at 1.2
| Date | Closing Price | 50 SMA | 50 EMA |
| 04 Wed Mar | 1.14 | 1.19 | 1.2 |
| 03 Tue Mar | 1.13 | 1.19 | 1.2 |
| 02 Mon Mar | 1.16 | 1.19 | 1.2 |
| 27 Fri Feb | 1.16 | 1.19 | 1.2 |
| 26 Thu Feb | 1.16 | 1.19 | 1.2 |
| 25 Wed Feb | 1.17 | 1.19 | 1.2 |
Audentes Therapeutics (BOLD) moving average of 100 SMA is at 1.22 and 100 EMA is at 1.32
| Date | Closing Price | 100 SMA | 100 EMA |
| 04 Wed Mar | 1.14 | 1.22 | 1.32 |
| 03 Tue Mar | 1.13 | 1.22 | 1.32 |
| 02 Mon Mar | 1.16 | 1.22 | 1.32 |
| 27 Fri Feb | 1.16 | 1.22 | 1.32 |
| 26 Thu Feb | 1.16 | 1.22 | 1.32 |
| 25 Wed Feb | 1.17 | 1.23 | 1.32 |
Audentes Therapeutics (BOLD) moving average of 200 SMA is at 1.2 and 200 EMA is at 1.57
| Date | Closing Price | 200 SMA | 200 EMA |
| 04 Wed Mar | 1.14 | 1.2 | 1.57 |
| 03 Tue Mar | 1.13 | 1.2 | 1.57 |
| 02 Mon Mar | 1.16 | 1.2 | 1.57 |
| 27 Fri Feb | 1.16 | 1.2 | 1.57 |
| 26 Thu Feb | 1.16 | 1.21 | 1.57 |
| 25 Wed Feb | 1.17 | 1.21 | 1.57 |
Xoma Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Xoma Corporation, about 1.55% more returns!
Audentes Therapeutics has performed better than Therapeuticsmd Inc in short term. Holding Audentes Therapeutics could be a better choice for now!
Sangamo Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Sangamo Therapeutics, about 9.7% more returns!
Pro Dex has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Pro Dex, about 20.38% more returns!
Audentes Therapeutics has performed better than Medpace Holdings in short term. Holding Audentes Therapeutics could be a better choice for now!
Karyopharm Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Karyopharm Therapeutics, about 45.66% more returns!
Audentes Therapeutics has performed better than Ironwood Pharmaceuticals in short term. Holding Audentes Therapeutics could be a better choice for now!
Iradimed Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 6.59% more returns!
Audentes Therapeutics has performed better than Amicus Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Fulgent Genetics in short term. Holding Audentes Therapeutics could be a better choice for now!
Fate Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Fate Therapeutics, about 33.51% more returns!
Editas Medicine has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Editas Medicine, about 27.34% more returns!
Corbus Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Corbus Pharmaceuticals, about 9.35% more returns!
Audentes Therapeutics has performed better than Alkermes Plc in short term. Holding Audentes Therapeutics could be a better choice for now!
Akari Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Akari Therapeutics, about 4.11% more returns!
Audentes Therapeutics Technical analysis of indicators
Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Audentes Therapeutics in short term but the buy signal is initial and weak.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Audentes Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Audentes Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.16 and Audentes Therapeutics BOLD stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BOLD Experts View which covers a lot of information including buying and selling signals
BOLD future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
